Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms.

Otsuru S, Gordon PL, Shimono K, Jethva R, Marino R, Phillips CL, Hofmann TJ, Veronesi E, Dominici M, Iwamoto M, Horwitz EM.

Blood. 2012 Aug 30;120(9):1933-41. doi: 10.1182/blood-2011-12-400085.

3.

Upregulating CXCR4 in human fetal mesenchymal stem cells enhances engraftment and bone mechanics in a mouse model of osteogenesis imperfecta.

Jones GN, Moschidou D, Lay K, Abdulrazzak H, Vanleene M, Shefelbine SJ, Polak J, de Coppi P, Fisk NM, Guillot PV.

Stem Cells Transl Med. 2012 Jan;1(1):70-8. doi: 10.5966/sctm.2011-0007.

4.

Local transplantation is an effective method for cell delivery in the osteogenesis imperfecta murine model.

Pauley P, Matthews BG, Wang L, Dyment NA, Matic I, Rowe DW, Kalajzic I.

Int Orthop. 2014 Sep;38(9):1955-62. doi: 10.1007/s00264-013-2249-y.

6.

Pre- and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experience.

Götherström C, Westgren M, Shaw SW, Aström E, Biswas A, Byers PH, Mattar CN, Graham GE, Taslimi J, Ewald U, Fisk NM, Yeoh AE, Lin JL, Cheng PJ, Choolani M, Le Blanc K, Chan JK.

Stem Cells Transl Med. 2014 Feb;3(2):255-64. doi: 10.5966/sctm.2013-0090.

7.

Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy.

Gioia R, Panaroni C, Besio R, Palladini G, Merlini G, Giansanti V, Scovassi IA, Villani S, Villa I, Villa A, Vezzoni P, Tenni R, Rossi A, Marini JC, Forlino A.

Stem Cells. 2012 Jul;30(7):1465-76. doi: 10.1002/stem.1107.

8.

Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties.

Vanleene M, Saldanha Z, Cloyd KL, Jell G, Bou-Gharios G, Bassett JH, Williams GR, Fisk NM, Oyen ML, Stevens MM, Guillot PV, Shefelbine SJ.

Blood. 2011 Jan 20;117(3):1053-60. doi: 10.1182/blood-2010-05-287565.

9.

Ex Vivo Expanded Allogeneic Mesenchymal Stem Cells With Bone Marrow Transplantation Improved Osteogenesis in Infants With Severe Hypophosphatasia.

Taketani T, Oyama C, Mihara A, Tanabe Y, Abe M, Hirade T, Yamamoto S, Bo R, Kanai R, Tadenuma T, Michibata Y, Yamamoto S, Hattori M, Katsube Y, Ohnishi H, Sasao M, Oda Y, Hattori K, Yuba S, Ohgushi H, Yamaguchi S.

Cell Transplant. 2015;24(10):1931-43. doi: 10.3727/096368914X685410.

PMID:
25396326
10.

Growth hormone injections improve bone quality in a mouse model of osteogenesis imperfecta.

King D, Jarjoura D, McEwen HA, Askew MJ.

J Bone Miner Res. 2005 Jun;20(6):987-93.

11.

Gene targeting of mutant COL1A2 alleles in mesenchymal stem cells from individuals with osteogenesis imperfecta.

Chamberlain JR, Deyle DR, Schwarze U, Wang P, Hirata RK, Li Y, Byers PH, Russell DW.

Mol Ther. 2008 Jan;16(1):187-93.

12.

Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta.

Jones GN, Moschidou D, Abdulrazzak H, Kalirai BS, Vanleene M, Osatis S, Shefelbine SJ, Horwood NJ, Marenzana M, De Coppi P, Bassett JH, Williams GR, Fisk NM, Guillot PV.

Stem Cells Dev. 2014 Feb 1;23(3):262-76. doi: 10.1089/scd.2013.0132.

14.
15.

Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta.

Horwitz EM, Prockop DJ, Gordon PL, Koo WW, Fitzpatrick LA, Neel MD, McCarville ME, Orchard PJ, Pyeritz RE, Brenner MK.

Blood. 2001 Mar 1;97(5):1227-31.

17.

Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice.

Guillot PV, Abass O, Bassett JH, Shefelbine SJ, Bou-Gharios G, Chan J, Kurata H, Williams GR, Polak J, Fisk NM.

Blood. 2008 Feb 1;111(3):1717-25.

18.

Extracellular matrix stoichiometry in osteoblasts from patients with osteogenesis imperfecta.

Fedarko NS, Robey PG, Vetter UK.

J Bone Miner Res. 1995 Jul;10(7):1122-9.

PMID:
7484289
19.

CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII.

Fratzl-Zelman N, Morello R, Lee B, Rauch F, Glorieux FH, Misof BM, Klaushofer K, Roschger P.

Bone. 2010 Mar;46(3):820-6. doi: 10.1016/j.bone.2009.10.037.

20.

In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta.

Panaroni C, Gioia R, Lupi A, Besio R, Goldstein SA, Kreider J, Leikin S, Vera JC, Mertz EL, Perilli E, Baruffaldi F, Villa I, Farina A, Casasco M, Cetta G, Rossi A, Frattini A, Marini JC, Vezzoni P, Forlino A.

Blood. 2009 Jul 9;114(2):459-68. doi: 10.1182/blood-2008-12-195859.

Items per page

Supplemental Content

Support Center